Effects of recombinant human erythropoietin in normal humans.
This review describes some of the physiological effects of recombinant human erythropoietin (EPO) in healthy humans. At the blood level EPO increases the arterial O(2) content not only by increasing red blood cell volume, but also by an equally important decrease in plasma volume. Well before that, EPO causes a prompt decrease in plasma levels of renin and aldosterone. Renal clearance studies suggest that EPO decreases renal proximal tubular reabsorption rate leading to activation of the tubuloglomerular feedback mechanism and a fall in glomerular filtration rate. Thus, treatment with EPO may result in suppression of endogenous EPO production through a decrease in intrarenal oxygen consumption. EPO elevates the arterial blood pressure even in healthy subjects. The receptor for EPO is present in many tissues. However, the functional effects of EPO in the skeletal muscle seem limited, and although it has been speculated that non-erythropoietic effects of EPO (angiogenesis, shift in muscle fibre types, cognitive effects) may be responsible for the increase in exercise performance, this has not been confirmed. EPO-induced haemodynamic effects call for careful monitoring during the administration period. The metabolic, hormonal and renal effects of EPO do not seem to range beyond physiologically acceptable limits and are reversible. Taken together, EPO seems safe to use for experimental purposes in healthy volunteers.
Lundby
Carsten
C
Center for Integrative Human Physiology, University of Zurich, Institute of Physiology, Room 23 H 6, Winterthurerstr. 190, 8057 Zürich, Switzerland. carsten.lundby@access.uzh.ch
Olsen
Niels Vidiendal
NV
D000818:Animals; D048429:Cell Size / Q000187:drug effects; D004912:Erythrocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D004920:Erythropoiesis / Q000187:drug effects / Q000502:physiology; D004921:Erythropoietin / Q000494:pharmacology* / Q000502:physiology*; D017079:Exercise Tolerance / Q000187:drug effects / Q000502:physiology*; D006454:Hemoglobins / Q000096:biosynthesis; D006801:Humans; D018482:Muscle, Skeletal / Q000187:drug effects / Q000502:physiology*; D010953:Plasma Volume / Q000187:drug effects / Q000502:physiology
D006454:Hemoglobins; D004921:Erythropoietin
Stroke. 2009 Dec;40(12):e647-56
19834012
Psychopharmacology (Berl). 2009 Nov;207(1):133-42
19705104
J Am Soc Nephrol. 2005 Apr;16(4):892-8
15728783
Clin J Am Soc Nephrol. 2009 Feb;4(2):470-80
19218474
Kidney Int. 1991 Feb;39(2):259-65
2002640
Blood. 2010 May 27;115(21):4264-72
20124513
J Physiol. 2007 Jan 1;578(Pt 1):309-14
17095558
Mol Psychiatry. 2007 Feb;12(2):206-20
17033631
Lancet. 2007 Feb 3;369(9559):381-8
17276778
N Engl J Med. 1999 Sep 16;341(12):913-5
10486426
PLoS One. 2009 Jun 12;4(6):e5894
19521513
Pflugers Arch. 2003 Nov;447(2):231-8
14551773
Blood. 2009 Jun 25;113(26):6707-15
19264680
Eur J Appl Physiol. 2002 Mar;86(5):442-9
11882931
Anal Biochem. 2002 Dec 15;311(2):119-26
12470670
Nephrol Dial Transplant. 1997 May;12(5):924-32
9175044
J Appl Physiol (1985). 2010 Aug;109(2):476-83
20522733
Am J Obstet Gynecol. 2003 Apr;188(4):993-6
12712099
Eur J Appl Physiol. 2007 Dec;102(1):41-4
17882450
J Intern Med. 1991 Feb;229(2):125-30
1997637
Exp Brain Res. 2008 Jan;184(3):313-21
17828390
Haematologica. 2000 Jun;85(6):564-72
10870111
Am J Physiol. 1991 Nov;261(5 Pt 2):F880-9
1951720
Med Sci Sports Exerc. 1999 May;31(5):639-45
10331881
Nephrol Dial Transplant. 1998 May;13(5):1200-5
9623554
J Investig Med. 2009 Jun;57(5):650-4
19491629
Nephrol Dial Transplant. 1993;8(1):93
8381946
Eur J Haematol. 2007 Mar;78(3):183-205
17253966
J Appl Physiol (1985). 2008 Aug;105(2):417-9
18583375
Hypertension. 1999 Mar;33(3):894-9
10082505
Kidney Int. 1996 Oct;50(4):1255-61
8887285
Kidney Int. 2001 Jul;60(1):83-6
11422739
Scand J Med Sci Sports. 2006 Feb;16(1):35-40
16430679
Am J Physiol. 1995 Mar;268(3 Pt 2):F455-60
7900845
Eur J Appl Physiol. 2007 Nov;101(4):481-6
17668232
Med Sci Sports Exerc. 2000 Jul;32(7):1238-43
10912888
Pflugers Arch. 2000 Apr;439(6):838-44
10784360
N Engl J Med. 2009 Nov 19;361(21):2019-32
19880844
Eur J Endocrinol. 2009 Sep;161(3):427-34
19515792
PLoS One. 2008 Aug 20;3(8):e2996
18714372
Am J Med Sci. 2007 Jul;334(1):65-71
17630596
J Appl Physiol (1985). 2008 Apr;104(4):1154-60
18218911
J Sports Sci. 2006 Apr;24(4):383-91
16492602
Adv Exp Med Biol. 2003;543:73-87
14713115
Am J Nephrol. 1996;16(4):304-8
8739283
Blood. 2007 Jun 1;109(11):4724-31
17311997
Curr Opin Oncol. 2010 Jul;22(4):307-11
20498598
J Physiol. 2011 Mar 15;589(Pt 6):1273-81
20724370
J Physiol. 2005 Oct 15;568(Pt 2):639-52
16081477
Am J Hypertens. 1990 Jan;3(1):76-80
2405885
J Appl Physiol (1985). 2008 Aug;105(2):581-7
18535134
Br J Clin Pharmacol. 1992 Oct;34(4):363-5
1457271